CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
CUPR

4.95 USD
-0.01
0.20%
At close Apr 17, 4:00 PM EDT
1 day
-0.20%
5 days
21.92%
1 month
10.49%
3 months
10.49%
6 months
10.49%
Year to date
10.49%
1 year
10.49%
5 years
10.49%
10 years
10.49%
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Research analyst outlook

We haven’t received any recent analyst ratings for CUPR.

Financial journalist opinion

Based on 3 articles about CUPR published over the past 30 days

Positive
Seeking Alpha
1 week ago
U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility
Seven IPOs and one SPAC debuted this week. One IPO and three SPACs submitted initial filings. Two sizable deals are set to lead the IPO calendar in the coming week.
U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility
Neutral
GlobeNewsWire
1 week ago
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
SINGAPORE, April 11, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector, today announced the closing of its previously announced initial public offering of an aggregate 3,000,000 Class A Ordinary Shares (“the Offering”) at a price of $4.00 per share (“the Offering Price”) to the public, for a total of $12.0 million of gross proceeds to the Company, before deducting underwriting discounts and offering expenses.
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
Neutral
GlobeNewsWire
1 week ago
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
SINGAPORE, April 10, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector, today announced the pricing of its firm commitment initial public offering of an aggregate 3,000,000 shares of its Class A Ordinary Shares (“the Offering”), all of which are being offered by CUPR at a public offering price of $4.00 per share (“the Offering Price”).
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
Charts implemented using Lightweight Charts™